Male Breast Cancer Terminated Phase 2 Trials for RG-4733 (DB11870)

IndicationStatusPhase
DBCOND0028546 (Male Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs